Skip to main content

Parkinson's Disease clinical trials at UC Davis

2 research studies open to eligible people

Showing trials for
  • A Dose Selection Study of Light Therapy for Impaired Sleep in Parkinson’s Disease

    open to eligible people ages 45 years and up

    This study aims to determine the most effective dose of light therapy to improve sleep in people with Parkinson's Disease. Four groups of participants will receive bright-white or dim-red light therapy at different times throughout the day.

    Sacramento, California and other locations

  • SHINE Study: Testing a New Oral Drug to Treat Parkinson's Disease With Dyskinesia

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 18-80

    This is a two-part, double-blind, placebo-controlled, randomized, multicenter Phase 2 clinical trial of JM-010 in patients with Parkinson's Disease.

    Detroit, Michigan and other locations